Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.
P Brito-ZerónB KostovR SolansG FraileC Suárez-CuervoA CasanovasF J RascónR QannetaR Pérez-AlvarezM RipollM AkasbiB PinillaJ A BoschJ Nava-MateosB Díaz-LópezM L Morera-MoralesH GheitasiS RetamozoManuel Ramos-Casalsnull nullPublished in: Annals of the rheumatic diseases (2014)
Patients with primary SS, who present at diagnosis with high systemic activity (ESSDAI ≥14) and/or predictive immunological markers (especially those with more than one), are at higher risk of death.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- rheumatoid arthritis patients
- ankylosing spondylitis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- type diabetes
- case report
- cardiovascular events
- patient reported outcomes
- free survival
- patient reported